Aviado · Research
Longevity Daily
Sunday, October 4, 2026
Listen
Today's Brief
Today's strongest thread is evidence scrutiny — who does this actually work for, and has the science been read correctly? The lead story finds rapamycin significantly increasing cerebral blood flow in healthy APOE4 carriers, one of the most actionable brain-health findings in months. A landmark audit dismantles two widely-cited collagen meta-analyses, while a 60-year senescence review concludes that no senolytic drug has yet delivered in humans. Aviado's pomegranate extract analysis adds a precision lens: test your CRP first, because the benefit disappears if you're not already inflamed.
10 stories7 peer-reviewed1 Aviado original
Cognitive Health & Neuroprotection
Rapamycin Boosts Brain Blood Flow in Adults at Highest Alzheimer's Risk
If you carry the APOE4 gene variant — the strongest known genetic risk factor for Alzheimer's disease — this is the most directly relevant longevity finding in months. A University of Missouri study published September 10, 2026 in the Journal of Cerebral Blood Flow and Metabolism found that a low daily dose of rapamycin meaningfully increased cerebral blood flow in healthy, middle-aged APOE4 carriers, a population facing up to 12× higher lifetime dementia risk. Reduced brain perfusion is one of the earliest detectable precursors of cognitive decline, making this a potential early-intervention window. The study adds to a rapidly growing clinical signal that rapamycin may have a meaningful role well before any dementia symptoms appear.
Read more →Not All Exercise Protects Your Brain — One Type Is Linked to Higher Dementia Risk
The received wisdom that any exercise is brain-protective turns out to be more complicated. Researchers found that specific types of physical activity are associated with elevated dementia risk rather than reduced risk, suggesting that exercise type and context matter at least as much as frequency or volume. The finding — adapted from The Conversation and based on NIHR- and UKRI-funded research — calls for a more nuanced approach to exercise prescriptions specifically targeting long-term cognitive health.
Read more →Supplements & Compounds
The Science Behind Oral Collagen Supplements Just Got Audited — and It Failed
Two meta-analyses that have been widely cited to justify oral hydrolyzed collagen supplements — de Miranda 2021 and Pu 2023 — have been re-examined by Grimes and Mahto and found to be riddled with errors: data entry mistakes, standard errors misidentified as standard deviations, misclassified measurement methods, and invalid pooling of non-comparable outcomes. The positive conclusions on skin hydration and elasticity do not survive scrutiny. If you're spending money on collagen peptides for skin benefits, the honest answer is the evidence base is now considerably weaker than label claims suggest.
Read more →Taking B12 But Still Deficient? Your Other Medications Are Likely the Problem
A large number of people supplementing B12 still test deficient, and two common longevity-adjacent drugs are frequently the cause. Long-term metformin — widely used for metabolic health and increasingly as an anti-aging intervention — directly reduces B12 absorption and lowers blood concentrations. Proton-pump inhibitors (PPIs) interfere with absorption of food-bound B12 by suppressing the stomach acid needed to release it; if you're on either drug, standard oral B12 may not be sufficient and sublingual or methylcobalamin forms should be considered.
Read more →Pomegranate Extract Only Works If You're Already Inflamed — Here's the Precision Protocol
Most people taking pomegranate extract for inflammation are wasting their money — unless their baseline inflammatory markers are already elevated. Aviado's clinical data review shows that if your CRP is above 2 mg/L, 500 mg of pomegranate extract daily (standardized to 30% punicalagins, split into two doses with meals) can reduce CRP by up to 2.5 mg/L over 8 weeks; if your markers are already in a healthy range, the effect is near zero. This precision framework — test first, supplement only if indicated, retest to confirm response — is a model for how to approach anti-inflammatory supplementation generally.
Read the full Aviado analysis →Research & Papers
Four Simple Biomarkers Predict Longevity Almost as Well as 21 Organ-Specific Aging Clocks
Edinburgh researchers followed 861 adults born in 1936 for 16 years, testing 23 different biological age measures at age 73 to determine which best predicted who survived. While plasma protein clocks estimating biological age across 11 organs did predict mortality — with liver, immune, and heart markers showing the strongest signal — a much simpler panel of four measures captured the majority of that predictive value. The practical implication: you may not need an expensive multi-organ proteomic test to get a meaningful read on your aging trajectory.
Read more →Sixty Years of Senescence Research — and Senolytics Still Haven't Delivered in Humans
A landmark historical review from Marco Demaria's group in Groningen traces cellular senescence from a 1961 cell-culture curiosity to today's most hyped drug target category. The sobering bottom line: despite compelling mouse data and decades of investment, no senolytic drug — including the widely self-experimented dasatinib/quercetin combination — has yet demonstrated clear clinical benefit in human trials. Senescence turns out to be deeply context-dependent, sometimes suppressing tumors, facilitating wound healing, and shaping embryonic development, which means indiscriminate senolytic use carries real and underappreciated risks.
Read more →Steve Horvath on Why 10,000 Steps Won't Reverse Aging — and What His Epigenetic Data Actually Shows
Steve Horvath, the biostatistician who created the foundational pan-tissue epigenetic aging clock, sat down with longevity author Dan Buettner to unpack what DNA methylation biomarkers actually reveal about biological aging. His core message: popular lifestyle interventions do register on epigenetic clocks, but rarely at the magnitude longevity enthusiasts believe — and the architecture of the clocks themselves shapes what interventions appear to work. For anyone using epigenetic age testing as a feedback loop for lifestyle or supplement changes, this dialogue is essential context for interpreting your results.
Read more →Lifestyle & Nutrition
A Fasting Mimicking Diet Reversed 2.5 Years of Biological Aging in 15 Days — What the RCT Actually Found
A 2024 Nature Communications RCT had participants complete three separate 5-day cycles of a fasting mimicking diet — 15 total days spread across three months — and measured biological age using multiple epigenetic clocks before and after. The result: an average reversal of approximately 2.5 biological aging years across the cohort. Important caveat: the study measured epigenetic biomarkers of biological age, not lifespan, and the article interpreting the findings is a Substack piece, so reading the primary Nature Communications paper directly is recommended before adjusting your own protocol.
Read more →Industry & Policy
Cambrian Bio Unveils Plans for a First-in-Class Exercise-Mimicking Drug at Major Aging Conference
Cambrian Biopharma, led by CEO James Peyer, announced at the Aging Research and Drug Discovery (ARDD) conference that it plans to develop a new class of mTOR inhibitors designed to replicate the metabolic and longevity benefits of physical exercise. The drug is positioned primarily for people who cannot exercise adequately due to age, disease, or disability. While exercise mimetics have been a longevity research goal for decades, no compound has yet matched the full systemic benefits of actual physical activity — making this an ambitious but high-risk program to watch.
Read more →